Clinical Trial: Pan-European Survey on the Under Treatment of Hypercholesterolemia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Pan-European Survey on the Under Treatment of Hypercholesterolemia

Brief Summary: The survey try to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task Force guidelines, overall and by country.·

Detailed Summary:
Sponsor: AstraZeneca

Current Primary Outcome: The number and percentage of patients achieving the LDL-C goals, according to the Third Joint European Task Force guidelines, overall and by country.

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: AstraZeneca

Dates:
Date Received: October 11, 2007
Date Started: January 2006
Date Completion:
Last Updated: November 19, 2007
Last Verified: November 2007